FDA Amends Animal Drug Regulations to Reflect Change of Sponsor

Summary

The Food and Drug Administration (FDA) is updating its animal drug regulations to reflect a change in sponsor for 30 approved new animal drug applications (NADAs) from Pfizer, Inc., to Phibro Animal Health, Inc., with the aim of improving accuracy and clarity in the agency's rules.